๐ฐ Bedema News
Page 7 - Bedema News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bedema. Real-time updates on events, politics, business and more.
April 12, 2023
1. Compared to placebo, monthly garadacimab significantly reduced the number of hereditary angioedema attacks per month. 2. Overall, garadacimab was well-tolerated, with the most common adverse events being upper respiratory tract infections, nasopharyngitis, and headaches. Evidence Rating Level: 1 (Excellent) Study Rundown: Hereditary angioedema (HAE) is a rare genetic disorder that is characterized by recurring
March 27, 2023
Mustard is one of the widely used and best-known ingredients in Indian cooking. Even though it is highly nutritious, and offers immense health benefits, over usage of mustard can be extremely dangerous. Read on to know some serious side effects which include allergies, cardiovascular issues, lung cancer, and dropsy. It also causes anemia, which can lead to breathlessness, headaches, and dizziness.
March 23, 2023
Nothing to show for it. this months of battles have turned the countryside, and the town of velyka novosilka into a wasteland, where civilians and the military come under daily russian bombardment. our correspondent, quentin sommerville and camera journalist darren conway have sent this report which you can see in full on bbc news and on our website later today. this is a daily duty for dema. for months, the first bank gate have been under russian attack. but they have barely given the enemy an ...
March 14, 2023
Oxurion Provides Update on Recruitment for KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular Edemaand Announces Board Changes Trial has now enrolled more
March 13, 2023
Do you have concerns over the proposed managed homeless site for the county? You can raise those concerns today. Supervisors Chris Coursey and James Gore will
March 7, 2023
In a recent article published in the United States (U.S.) Centers for Disease Control and Prevention's (CDC)ย Morbidity and Mortality Weekly Report, a team of researchers discussed the medical countermeasures and clinical considerations for treating severe manifestations of Mpox.
March 2, 2023
Andrew N. Wilner, MD, and Richard J. Caselli, MD, discuss developments in the treatment of Alzheimers disease.
February 20, 2023
In a rapid communication published in the journal Eurosurveillance, researchers presented the interim results of a medium-term follow-up [three weeks to twenty weeks following MPOX virus infection follow-up study comprising patients attending sexual health clinics in Belgium.
February 10, 2023
A new international trial has shown large benefits of thrombectomy in patients with ischemic strokes with a large core volume, which should lead to a change in clinical practice.
February 9, 2023
ApTOLL reduced mortality and infarct size and improved disability for stroke patients undergoing endovascular therapy, preliminary results show.